Skip to main content
Gianelli & Morris attorneys Alex Gianelli, Joshua S. Davis, Robert S. Gianelli and Loring Rose

Protecting insuredrights since 1979

We fight insurance companies that refuse to pay.

Insurance companies don’t always play fair. Our insurance claim attorneys help policyholders fight denied, delayed, or underpaid insurance claims and recover what they’re owed.

Free Consultation

California Experimental Treatment Denial Lawyer

Free Consultation

Under California law, a health plan's decision to deny care as "experimental" or "investigational" can generally be challenged. The usual route is a grievance with the plan, followed by an Independent Medical Review through the Department of Managed Health Care (DMHC) or the Department of Insurance (CDI). For DMHC plans, the IMR application is ordinarily due within six months of the plan's written grievance response under Cal. Health & Safety Code § 1374.30, and the DMHC can accept later applications for good cause.

Your oncologist, surgeon, or specialist recommended a treatment, and your health plan answered with one word: experimental. You're probably wondering whether that label is the end of the road. Often it is not. Robert S. Gianelli is a Gianelli & Morris partner who represents California policyholders in health, life, disability, and property insurance disputes, and his cases include Arce v. Kaiser Foundation Health Plan, a class action over the denial of autism treatment. This page explains how experimental denials are reviewed in California, which deadlines can run at the same time, and when a denial may support a bad-faith claim.

Gianelli & Morris has focused on representing policyholders against insurers since 1979, bringing class actions that challenged health plan denials of reconstructive surgery, prosthetic limbs, and autism treatment. For bad-faith cases, we work on contingency: our fees are a percentage of any award we recover. Bring your denial letter and your plan documents, then call 213-489-1600 for a free consultation to discuss your legal options.

Key Takeaways

  • A California health plan denial of medical necessity must come from a licensed physician or competent licensed health care professional, in writing, with the criteria and clinical reasons used (Cal. Health & Safety Code § 1367.01).
  • DMHC-regulated plans must resolve a grievance within 30 days, or within 72 hours when the case is expedited because of an imminent and serious threat to health.
  • If the DMHC adopts an IMR decision that the service is medically necessary, the plan must authorize the service or reimburse for care already received within five working days (Cal. Health & Safety Code § 1374.34).
  • Insurance Code § 790.03 does not give policyholders a private right to sue. The lawsuit itself is a common-law bad-faith claim, and § 790.03 sets the conduct standard the Department of Insurance enforces.
  • Private-employer group plans are generally governed by ERISA, which limits lawsuit remedies. Members of insured employer HMO plans still keep their DMHC grievance and IMR rights.

What Is at Stake When a Health Plan Calls Your Treatment Experimental?

An experimental or investigational denial is not just a paperwork problem: it can decide whether you receive the treatment your doctor believes gives you the best chance, and it starts several legal clocks at once. Most people who reach this page are dealing with a serious diagnosis. The denial lands at the worst possible moment.

The medical cost of waiting

Some treatments only make sense within a window. A surgery, an infusion, or a newer device may be recommended because standard options have stopped working or never fit your condition. Each week spent on appeals is a week your condition can change. That's why California law builds in expedited review when there is an imminent and serious threat to your health, and why requesting it early matters.

The financial cost of paying out of pocket

Some patients decide they can't wait and pay for the treatment themselves. Others borrow, drain savings, or set up crowdfunding pages. If you later win an IMR, the plan must reimburse care already rendered (§ 1374.34). But an IMR win doesn't compensate for pain, worsening, or other harm caused by the delay. That is a separate question, one that belongs to a bad-faith or tort analysis.

The procedural cost: deadlines that overlap

Here's the part people miss. A single denial letter can trigger a grievance deadline, an IMR window, a policy suit-limitation clause, and statutes of limitations for a lawsuit. They don't run in a neat line. Missing one can close a path even while another stays open. The rest of this page lays out each one, with the exceptions that change the answer.

For a broader look at how these disputes unfold, our overview of fighting health care denials in California covers denials beyond the experimental label.

How We Evaluate an Experimental Treatment Denial: Gate, Record, Remedy

We organize the evaluation of a California health insurance denial in three stages (Gate, Record, Remedy), covering six steps that identify which law governs your plan, which deadlines apply, how strong the denial letter really is, and which remedy fits. It's a framework for asking the right questions in the right order. It is not a promise of a particular result, and every matter needs an individual calculation by counsel.

Gate: Identify the governing path and lock down the clock

Step 1: Identify the governing path. Who sponsors and regulates your coverage shapes everything after. HMOs and most managed-care plans fall under the Knox-Keene Act and the DMHC. Health insurance policies regulated by the CDI follow the Insurance Code. A private employer-sponsored group plan generally points toward ERISA, where federal law has been held to preempt state bad-faith tort claims. Gianelli & Morris does not handle ERISA-governed employee benefit cases, so for those plans this step works as a screen. We explain why a different path applies rather than taking the case. If the governing law is unclear, we resolve that first.

Step 2: Lock down the clock. We read the policy's suit clause and identify every denial date that might trigger a deadline. If a deadline is close, preserving the claim comes before refining strategy. Documents we ask for at this stage include your Evidence of Coverage or policy, enrollment and premium records, any employer plan documents, your insurance ID card, and every denial and appeal letter with its date.

Record: Take the denial apart and choose the review route

Step 3: Take the denial letter apart. California sets specific requirements for how a health plan denies care. Gaps such as a non-clinician reviewer, missing criteria, boilerplate reasons, or a late decision can strengthen both the administrative appeal and any later claim that the insurer acted unreasonably. A denial that looks complete on its face shifts the focus to the medical merits instead.

Step 4: Choose the review route. For DMHC plans that usually means a grievance, then IMR. CDI policies have their own IMR. If your condition is urgent, we push for expedited review. The submission is built around your treating physician's evidence, medical records, and peer-reviewed literature. We also decide early whether the matter warrants litigation alongside or after administrative review.

Remedy: Test the investigation and match the remedy to the scale

Step 5: Test the insurer's investigation. We look at the full claim file, the reviewer notes, the internal guidelines applied, and the communications log. A one-sided review or ignored medical evidence can support a tort claim. A documented, reasoned medical disagreement may point instead toward a contract claim or administrative relief. We check for an arbitration provision at this stage, because it affects where a claim can be heard.

Step 6: Match the remedy and the scale. Here we compare three options: an individual appeal, an individual lawsuit, or a broader challenge to a practice. Where a denial reflects a uniform policy, such as a blanket exclusion of a procedure, the firm's class action experience makes it worth asking whether other members face the same practice. Our firm has challenged plan-wide denials before, including class litigation over lumbar artificial disc replacement and a challenge to Blue Shield's blanket Coflex denials.

Past results and recognitions describe the firm's experience. They don't predict how any future matter will turn out.

Not sure which path your plan falls under? That's the first question we answer in a free case review. Call 213-489-1600 and have your denial letter nearby.

What Does "Experimental or Investigational" Mean Under a California Health Plan?

In California, there is no single statewide definition of "experimental" that every plan must use; the starting point is the definition written into your plan's Evidence of Coverage or policy, and that definition is then tested against medical and scientific evidence during review. The label often turns on whether a treatment has regulatory approval for your condition, whether it is considered standard of care, and what published studies show.

Evidence of Coverage is the plan document that describes what your health plan covers, what it excludes, and how it defines terms like "medically necessary" and "experimental." For most care, this document supplies the plan's definitions. One exception: California law sets its own definition of medically necessary treatment for mental health and substance use disorders in DMHC-regulated plans, and that statutory definition applies regardless of the plan's wording.

Common situations where the label appears

Experimental or investigational denials tend to arise in a few recognizable situations:

  • Off-label drug use. A medication approved for one condition is prescribed for another.
  • Newer surgical procedures or devices. A procedure has entered practice, but the plan's internal guidelines haven't caught up.
  • Treatments tied to clinical trials. Federal and California law address coverage of routine patient care costs for people in certain approved clinical trials, which is a separate question from whether the plan pays for the investigational drug itself.
  • Advanced prosthetics and equipment. Higher-function devices are sometimes treated as unproven. Our article on microprocessor prosthesis denials covers this pattern.

Why the label on your denial matters

A plan can frame the same refusal as a medical-necessity denial, an experimental-treatment denial, or a coverage exclusion, and that framing can change which review applies. If the DMHC treats a dispute as a pure coverage question rather than a medical one, it generally goes through the department's standard complaint process instead of IMR. That's one reason we read the denial language carefully before anything is filed. Our page on claims denied as experimental has more background on how these exclusions are written.

Utilization review is the process a health plan uses to decide whether a requested service is medically necessary and covered before, during, or after care. Under Cal. Health & Safety Code § 1367.01, only a licensed physician or a competent licensed health care professional may deny or modify a request for medical-necessity reasons. Routine prospective decisions must come within five business days of receiving the reasonably necessary information, and urgent decisions within 72 hours. The written denial must include a clear explanation, the criteria or guidelines used, and the clinical reasons.

Does a denial letter have to explain why the treatment is experimental? For a DMHC plan's medical-necessity decision, yes. Section 1367.01 requires a written explanation with the criteria and clinical reasons. A letter that simply says "experimental" without identifying the guideline relied on is a gap worth documenting. Our article on failing to explain a denial covers why that matters.

How Does an Experimental Denial Independent Medical Review Work in California?

Under California law, a member of a DMHC-regulated plan generally files a grievance with the plan first, then may apply to the DMHC for a free Independent Medical Review (IMR) if the plan upholds the denial or fails to resolve the grievance within 30 days (72 hours if expedited). For experimental or investigational denials affecting people with a life-threatening or seriously debilitating condition, a separate Knox-Keene provision requires an external, independent review of the coverage decision for enrollees who meet its criteria.

Independent Medical Review is a review by doctors who are not employed by your health plan. They examine your records and the medical evidence and decide whether the plan's denial should stand. When the DMHC adopts an IMR decision in your favor, the plan is bound to implement it.

Step one: the plan grievance

Every Knox-Keene plan must maintain a DMHC-approved grievance system and tell members how to use it under Cal. Health & Safety Code § 1368. The plan resolves a standard grievance within 30 days. Expedited review is a faster track for cases involving an imminent and serious threat to your health, and it shortens the plan's deadline to 72 hours. Our guide to California's health insurance grievance system explains what the plan must provide.

Your grievance is the first place to put your treating physician's reasoning on the record. A strong appeal letter for a health insurance denial addresses the plan's stated reason directly rather than restating the diagnosis.

Step two: applying for IMR

For a medical-necessity IMR, you generally must have filed a grievance first. In extraordinary and compelling cases, the DMHC may waive that prerequisite, and it can expedite delivery to the review organization when there is an imminent and serious threat to health under Cal. Health & Safety Code § 1374.31.

The application window runs from the qualifying periods or events in Cal. Health & Safety Code § 1374.30, not from the original denial. Applications must ordinarily be filed within six months of the plan's written response to the grievance, and the DMHC can accept later applications for good cause. No fee may be charged to you. The Independent Medical Review application is on the DMHC's website.

What the reviewers look at

For experimental and investigational disputes, the statutory criteria focus on your condition, your treating physician's assessment of standard therapies, and the medical and scientific evidence supporting the requested treatment. That makes the physician's letter the center of the file. Patients treated at Los Angeles research hospitals such as UCLA Health, Cedars-Sinai, or City of Hope often have specialists who can cite the specific studies behind a recommendation, and that citation work is worth asking for.

What happens if you win

Under Cal. Health & Safety Code § 1374.34, once the DMHC adopts an IMR decision finding the service medically necessary, the plan must promptly implement it. That means reimbursing the provider or enrollee for services already rendered within five working days, or authorizing services not yet rendered within five working days. The statute also prohibits plan conduct that prolongs the IMR process. Our firm's page on the role of the DMHC in health insurance denials and our summary of DMHC IMR data give more context.

What about Medi-Cal managed care members? Medi-Cal members in a Knox-Keene plan are not excluded from IMR, but Medi-Cal also has its own sequence. The member generally must first appeal to the plan within 60 days of the Notice of Action, and the state fair hearing window of 120 days opens from the plan's Notice of Appeal Resolution, not the original denial. Because the two paths interact, the order of filings should be confirmed before you act. The California Department of Health Care Services administers Medi-Cal.

What If Your Coverage Is a Department of Insurance Policy Instead of an HMO?

California health insurance policies regulated by the Department of Insurance follow the Insurance Code rather than the Knox-Keene Act, including parallel utilization-review rules and a separate Independent Medical Review system under Cal. Ins. Code § 10169. The steps look similar, but the agency, the forms, and some deadlines differ.

How to tell which agency regulates your plan

Look at your ID card and Evidence of Coverage or policy. HMOs and most managed-care products, including every Kaiser HMO, are DMHC plans. Many PPO policies sold by insurance companies are CDI-regulated. If the documents don't make it clear, the plan is required to tell you how to reach its regulator, and either agency can confirm. The Department of Insurance consumer help page explains how CDI handles complaints.

Claim-handling deadlines for CDI health policies

Under Cal. Ins. Code § 10123.13, a CDI-regulated health insurer must pay a complete claim, or notify the claimant in writing that it is contested or denied with the specific reasons, within 30 calendar days of receiving it. The 40-day accept-or-deny rule used for life, long-term care, and property claims does not apply to health insurance claims covered by § 10123.13. See Cal. Ins. Code § 10123.13.

CDI's Independent Medical Review

Cal. Ins. Code § 10169 establishes the Department of Insurance's IMR system for health insurance policies. The core idea is the same as DMHC review: outside physicians decide whether the denial was correct based on your records and the medical evidence.

The table below compares the main review paths side by side.

CDI's Independent Medical Review
Coverage typeRegulatorInternal review stepExternal reviewLawsuit remedies
HMO or managed-care plan (individual or public employer)DMHCPlan grievance, resolved within 30 days or 72 hours if expeditedDMHC IMR under H&S § 1374.30, ordinarily within six months of the grievance responseCalifornia contract and bad-faith claims generally available
CDI-regulated health insurance policyDepartment of InsuranceInsurer's internal review; claims decided within 30 calendar days under Ins. Code § 10123.13CDI IMR under Ins. Code § 10169California contract and bad-faith claims generally available
Insured private-employer HMO planDMHC for review rights; ERISA governs lawsuitsKnox-Keene grievance plus federal ERISA claim rulesDMHC IMR remains availableERISA remedies only; Gianelli & Morris does not handle ERISA cases
Self-funded private-employer planU.S. Department of LaborFederal ERISA claims procedureFederal external review process, not DMHCERISA remedies only; Gianelli & Morris does not handle ERISA cases
Government or church planDepends on plan structurePlan or insurer processDepends on whether the plan is DMHC- or CDI-regulatedGenerally retains California bad-faith remedies against the insurer

Does It Matter Whether Your Plan Comes Through a Private Employer?

Yes. Under federal law, a private employer's group health plan is generally governed by ERISA, which supersedes state laws that relate to employee benefit plans (29 U.S.C. § 1144) and replaces California's bad-faith tort remedies with a narrower federal claim. Government and church plans are exempt from ERISA and generally retain California bad-faith remedies against the insurer.

ERISA preemption is the rule that federal benefits law overrides state laws relating to most private employer plans. The statute contains an insurance savings clause, and later Supreme Court decisions narrowed some of the earlier reasoning, but the Supreme Court in Pilot Life Ins. Co. v. Dedeaux (1987) held state common-law bad-faith claims preempted for ERISA plans. See 29 U.S.C. § 1144.

What ERISA changes and what it doesn't

ERISA changes remedies. It does not erase the DMHC review path for insured plans. An insured employer plan that is a Knox-Keene plan keeps its members' grievance and IMR rights, and it must also meet the federal ERISA claims-procedure schedule. Self-funded employer plans fall outside the DMHC review path.

Lawsuit remedies are where the difference shows. Under 29 U.S.C. § 1132, a participant may sue to recover plan benefits, and recovery is generally limited to the benefit plus potential interest, attorney fees in the court's discretion (§ 1132(g)), and appropriate equitable relief (§ 1132(a)(3)). Bad-faith tort damages, punitive damages, and emotional-distress damages are not available. ERISA benefit suits can be filed in state or federal court.

Where Gianelli & Morris fits

We don't handle ERISA-governed employee benefit cases. If your plan is a private-employer plan, we can help you understand why your case follows a different path, and the U.S. Department of Labor (EBSA) provides information about federal claim rights.

Teachers, police officers, firefighters, and other public employees are in a different position. Their plans are not ERISA plans, so state remedies generally remain available, though plan structure and the defendant can matter. Our page on how public employee insurance denials are different explains the distinction.

When Does an Investigational Treatment Insurance Denial Become Bad Faith?

Under California law, every insurance policy carries an implied covenant of good faith and fair dealing, and an insurer that unreasonably withholds benefits from its own insured can be liable in tort (Gruenberg v. Aetna Ins. Co. (1973) 9 Cal.3d 566). A wrong denial is not automatically bad faith. The question is whether the insurer's conduct was unreasonable, and for ERISA-governed private-employer plans, this tort claim is generally unavailable.

The implied covenant of good faith and fair dealing is a duty California law reads into every insurance policy. It requires the insurer not to unfairly frustrate your right to receive the benefits you paid for, and it exists whether or not the policy spells it out.

The genuine dispute question

Insurers often argue that a disagreement about medicine is a "genuine dispute," not bad faith. The genuine dispute doctrine protects an insurer only where its position rests on a reasonable, good-faith investigation. In Wilson v. 21st Century Ins. Co. (2007) 42 Cal.4th 713, the California Supreme Court held that a jury could find bad faith where the insurer reached its medical conclusion without fairly investigating and disregarded the treating physician's evidence.

For an experimental denial, the bad-faith question usually turns on what the plan actually reviewed: your records, your doctor's reasoning, and the current literature, or only an internal guideline applied without looking at your situation.

Where Insurance Code § 790.03 fits

Cal. Ins. Code § 790.03 lists unfair claims settlement practices, but it creates no private right of action (Moradi-Shalal v. Fireman's Fund Ins. Cos. (1988) 46 Cal.3d 287). It is the conduct standard the Insurance Commissioner enforces. Its standards remain relevant evidence of what reasonable claims handling looks like, and the lawsuit itself is the common-law bad-faith claim. Our article on California Insurance Code 790.03 covers this in more depth.

What damages may be recoverable

The table below compares remedies. Every category depends on the facts and the evidence.

What damages may be recoverable
RemedyNon-ERISA bad-faith claim (individual, public employer, church plan)ERISA private-employer plan
Policy benefits wrongly withheldRecoverable as contract damagesRecoverable under 29 U.S.C. § 1132(a)(1)(B)
Attorney fees to recover benefitsBrandt fees recoverable as damages; fees for the bad-faith claim itself are notPossible in the court's discretion under § 1132(g)
Emotional distress caused by the bad faithMay be recoverable in tortNot available
Punitive damagesOnly on clear and convincing evidence of oppression, fraud, or maliceNot available
Interest and equitable reliefDepends on the claim and the courtPotential interest and appropriate equitable relief under § 1132(a)(3)

Brandt fees are attorney fees you reasonably incur to force an insurer to pay benefits it tortiously withheld. Under Brandt v. Superior Court (1985) 37 Cal.3d 813, they are recoverable as damages, though fees for pursuing the bad-faith claim itself are not. California's punitive damages statute requires clear and convincing evidence of oppression, fraud, or malice, so punitive damages are never assumed. Our page on bad faith insurance remedies walks through these categories.

How Long Do You Have to Act After an Experimental Treatment Denial?

California has several deadlines that can run at once after a health insurance denial, and accrual, tolling, and contractual limitation clauses in your policy can shorten or shift any of them. Treat the periods below as general rules. Prompt review by an attorney is the only reliable way to calculate your own.

How Long Do You Have to Act After an Experimental Treatment Denial?
DeadlineGeneral ruleAuthorityKey exception or caveat
DMHC plan grievance decisionPlan resolves within 30 days; 72 hours if expeditedKnox-Keene grievance system (H&S § 1368)Applies to DMHC-regulated plans only; ERISA plans also follow federal claim rules
DMHC IMR applicationOrdinarily within six months of the plan's written grievance responseH&S § 1374.30DMHC can accept later applications for good cause
CDI health claim decisionPay, contest, or deny in writing within 30 calendar daysIns. Code § 10123.13Applies to CDI-regulated health policies
Policy suit clause (CDI policies)No suit before 60 days after written proof of loss, none after three years from when proof of loss is requiredIns. Code § 10350.11The policy's own wording must be read; some clauses are more generous
Bad-faith tort claimTwo years, commonly from the insurer's unequivocal denialCCP § 339(1); Love v. Fire Ins. Exchange(1990)Accrual and tolling can shift the date; policy clauses also apply
Breach of the written policyFour years, commonly from the unequivocal denialCCP § 337(a)A policy suit-limitation clause may shorten the time

Why the "unequivocal denial" date matters

Courts commonly measure the limitations periods from the insurer's unequivocal denial, so identifying which letter counts is often the first legal question in the file. A series of letters, partial approvals, or ongoing review can make that date unclear. When it is unclear, counsel has to resolve it before relying on any deadline.

What if your situation is urgent?

Ask your doctor to state in writing that your condition poses an imminent and serious threat to your health. That statement supports expedited handling at the grievance stage and at IMR. Don't hold off on the grievance while you gather every possible document; you can add evidence as the review moves forward.

Health Insurance Results That Show How the Firm Handles Coverage Disputes

Gianelli & Morris has recovered hundreds of millions of dollars for policyholders, and its health coverage work includes class actions and a jury verdict involving reconstructive surgery, prosthetics, autism treatment, mental health care, and a delayed surgical referral. These matters are not all experimental-treatment cases, and they don't predict any future result. They show the kinds of coverage disputes the firm has litigated.

Health Insurance Results That Show How the Firm Handles Coverage Disputes
CaseCoverage issueType of matterReported result
Gallimore v. KaiserCalifornia reconstructive surgery law and excess skin removal after major weight lossClass action trialEstimated benefits to Kaiser members exceeding $150 million
LaRue v. Accountable Health Care, IPAFailure to provide a timely surgical referral by Health Net's contracted medical groupIndividual jury trial$7.2 million jury verdict against Accountable Health Care, IPA
Arce v. KaiserDenial of autism treatmentClass actionBasis of Robert Gianelli's California Lawyer Attorney of the Year Award
Trujillo v. United HealthcareCoverage for prosthetic limbsClass actionClass litigation over amputees' access to prosthetic limbs

What these cases have in common

Each one involved a coverage rule applied to people whose doctors said they needed care. That's the same tension at the center of an experimental denial. When a plan applies one guideline to every member who requests a treatment, the question of scale from Step 6 becomes real. You can read more about Gallimore and excess skin surgery denials on our site.

Recognition behind the work

Robert Gianelli received the California Lawyer Attorney of the Year (CLAY) Award, was twice a finalist for Consumer Attorney of the Year, and is a recipient of the Consumer Attorneys of California Street Fighter of the Year honor. The firm holds an AV Preeminent® rating. His attorney profile lists more of his cases.

Where Experimental Treatment Denial Cases Are Heard in Los Angeles County

In Los Angeles County, a California bad-faith lawsuit over a health insurance denial is filed in the Los Angeles County Superior Court and is ordinarily an unlimited civil case, not a "complex" case, which is a separate designation under the California Rules of Court. Your case notice and the department it's assigned to control where the case is actually heard.

State court or federal court

An insurer sued by a California resident can remove the case to federal court on diversity grounds only if the insurer is both incorporated and headquartered outside California and more than $75,000 is in controversy. For Los Angeles residents, that federal court is the U.S. District Court for the Central District of California. ERISA benefit claims, by contrast, can be filed in state or federal court. The California Courts website explains general civil procedures and self-help resources.

Arbitration clauses in health plans

Some health plans, including many Kaiser plans, require binding arbitration of disputes. That changes where a claim can be heard, which is why we check for an arbitration provision early. If a neutral arbitrator is proposed, a party generally must serve notice of disqualification within 15 calendar days of the arbitrator's disclosure (or of the failure to disclose), and one court-appointed arbitrator may be disqualified without cause under CCP § 1281.91.

Some proposed legislation would expand state oversight of health plan arbitration requirements, but readers should confirm the current status of any such law directly with the Legislature or the DMHC before relying on it.

The agencies involved

For Los Angeles residents, the administrative bodies are statewide: the California Department of Managed Health Care for Knox-Keene plans, the Department of Insurance for CDI-regulated policies, and the Department of Health Care Services for Medi-Cal. The firm's Los Angeles office handles matters from across California.

What Working With Gianelli & Morris Looks Like, Including Fees

Gianelli & Morris offers a free consultation to discuss your legal options, and for insurance bad-faith cases, our fees are taken as a percentage of any award we recover. For help limited to administrative steps such as a grievance or IMR, we explain fee arrangements during the free consultation rather than assuming one model fits.

What to bring to the first conversation

You'll get more out of a free case review if you bring:

  1. Every denial, grievance, and appeal letter, with dates
  2. Your Evidence of Coverage or policy, plus your ID card
  3. Your treating physician's recommendation and any letter of medical necessity
  4. Records of what you've paid out of pocket
  5. Any employer plan documents, if the coverage came through work

What happens next

We start with the Gate questions: who regulates your plan and which deadlines are already running. If your plan is a private-employer ERISA plan, we'll tell you so and explain why the path is different. If it isn't, we look at the denial letter, the review route, and whether the record suggests the insurer acted unreasonably. You'll get a straight explanation of options, including when an administrative review alone may be the right fit.

A firm that focuses on policyholders

We've represented policyholders for more than four decades, against insurers including Kaiser, Blue Shield, Anthem, United, and Cigna. The firm doesn't divide its attention with general personal injury work. That focus is what shaped the class actions described above.

The information on this page is for general informational purposes and does not constitute legal advice. Every case is different, and past results do not guarantee future outcomes. Please consult a qualified attorney about your specific situation.

Talk to us before the IMR window or a suit deadline closes

An experimental denial can start a six-month IMR window, a policy suit clause, and limitations periods all at once. If you're in Los Angeles or anywhere in California and your plan has refused treatment as experimental or investigational, call Gianelli & Morris at 213-489-1600 for a free consultation. We'll review the dates on your letters first.

Frequently Asked Questions

How much does an experimental treatment denial lawyer cost in California?

For insurance bad-faith cases, Gianelli & Morris works on contingency, meaning our fees are a percentage of any award we recover. For help limited to a grievance or Independent Medical Review, we explain fee arrangements during the free consultation instead of assuming one model.

You can reach us at 213-489-1600 to schedule that conversation.

My plan says the treatment is experimental. Is that decision final?

Usually not. In California, members of DMHC-regulated plans can file a grievance and then apply for Independent Medical Review, and CDI-regulated policies have their own IMR under Insurance Code § 10169. The plan's label is a starting point that outside physicians can test against your records and the medical evidence.

How long do I have to request an experimental denial independent medical review?

For DMHC plans, the IMR application must ordinarily be filed within six months of the plan's written response to your grievance under Health & Safety Code § 1374.30. The DMHC can accept later applications for good cause, but don't count on an extension. The six months runs from the grievance response, not the original denial.

How long do I have to file a lawsuit over a health insurance denial in California?

California courts generally apply a two-year period to bad-faith tort claims (CCP § 339(1)) and a four-year period to claims on the written policy (CCP § 337(a)), commonly measured from the insurer's unequivocal denial. Accrual, tolling, and contractual suit-limitation clauses in your policy can shorten or shift these dates, so have an attorney calculate yours.

What is my experimental treatment denial case worth?

There's no formula, and we won't give you an invented range. In a non-ERISA bad-faith case, damages may include the withheld benefits, Brandt fees, emotional distress caused by the bad faith, and punitive damages only on clear and convincing evidence of oppression, fraud, or malice. Private-employer ERISA plans are generally limited to the benefit, potential interest, discretionary attorney fees, and equitable relief.

I already paid for the treatment myself. Can I get that money back?

Possibly. If the DMHC adopts an IMR decision that the service was medically necessary, the plan must reimburse the provider or enrollee for services already rendered within five working days under Health & Safety Code § 1374.34. An IMR win doesn't compensate for pain or worsening caused by the delay, which is a separate bad-faith question.

My health plan comes through my employer. Can Gianelli & Morris help?

It depends on the employer. Private-employer group plans are generally governed by ERISA, and our firm does not handle ERISA-governed employee benefit cases, though members of insured employer HMO plans still keep DMHC grievance and IMR rights. Government and church plans, such as those covering teachers, police officers, and firefighters, generally retain California bad-faith remedies against the insurer.

Should I accept the plan's offer to cover a different treatment instead?

That's a medical decision to make with your doctor, not your insurer. Accepting an alternative doesn't necessarily waive your right to grieve the original denial, but you should confirm in writing what the plan is approving and ask your physician whether the alternative is appropriate for your condition before deciding.

Does every experimental denial count as insurance bad faith?

No. Under California law, bad faith requires that the insurer acted unreasonably, not just that it was wrong. Under Wilson v. 21st Century Ins. Co., an insurer that reached its medical conclusion without fairly investigating and disregarded the treating physician's evidence can face bad-faith liability, while a reasoned, documented disagreement may support only a contract claim or administrative relief.

Do I need a lawyer to file a grievance or IMR?

You don't need one to file; the DMHC IMR process is free and designed for members to use directly. A lawyer can help when the deadlines overlap, when the plan's label puts the dispute outside IMR, when an arbitration clause applies, or when the denial may support a bad-faith claim worth preserving.

Will my case go to trial?

Many disputes resolve at the grievance or IMR stage, and lawsuits can resolve before trial. Some plans require binding arbitration instead of court. If a lawsuit is filed in Los Angeles County, it's ordinarily an unlimited civil case in the Los Angeles County Superior Court, and the case notice and assigned department control where it is heard.

How long does an experimental treatment denial dispute take?

Timing depends on the path. A DMHC plan must resolve a grievance within 30 days, or 72 hours if expedited, and the IMR follows if the denial stands. A lawsuit takes longer and depends on the court, arbitration requirements, and whether the case is removed to federal court, so we explain the factors rather than predict a specific number of months.